Literature DB >> 17110238

Lipoprotein(a): a unique risk factor for cardiovascular disease.

Erdembileg Anuurad1, Michael B Boffa, Marlys L Koschinsky, Lars Berglund.   

Abstract

Lipoprotein(a) (Lp(a)) is present in humans and primates. It has many properties in common with low-density lipoprotein, but contains a unique protein moiety designated apo(a), which is linked to apolipoprotein B-100 by a single disulfide bond. International standards for Lp(a) measurement and optimized Lp(a) assays insensitive to isoform size are not yet widely available. Lp(a) is a risk factor for coronary artery disease, and smaller size apo(a) is associated with coronary artery disease. The physiologic role of Lp(a) is unknown.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17110238     DOI： 10.1016/j.cll.2006.07.002

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  25 in total

1.  Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.

Authors:  Nastaran Faghihnia; Sotirios Tsimikas; Elizabeth R Miller; Joseph L Witztum; Ronald M Krauss
Journal:  J Lipid Res       Date:  2010-08-16       Impact factor: 5.922

Review 2.  [Biomarkers in cardiology--state of the art 2007].

Authors:  Johannes Mair
Journal:  Wien Med Wochenschr       Date:  2007-02

3.  Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors.

Authors:  A Moleres; T Rendo-Urteaga; C Azcona; J A Martínez; S Gómez-Martínez; J R Ruiz; L A Moreno; A Marcos; A Marti
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

4.  Risk factors: Lipoprotein(a) and coronary disease-moving closer to causality.

Authors:  John Danesh; Sebhat Erqou
Journal:  Nat Rev Cardiol       Date:  2009-09       Impact factor: 32.419

Review 5.  Novel markers of inflammation in atherosclerosis.

Authors:  Salim S Virani; Venkateshwar R Polsani; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

6.  Early atherogenesis and visceral fat in obese adolescents.

Authors:  A H Slyper; H Rosenberg; A Kabra; M J Weiss; B Blech; S Gensler; M Matsumura
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

Review 7.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 8.  Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.

Authors:  Luis R Lopez; Kazuko Kobayashi; Yukana Matsunami; Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

9.  The role of oxidized phospholipids in atherosclerosis.

Authors:  Judith A Berliner; Norbert Leitinger; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2008-12-04       Impact factor: 5.922

Review 10.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.